Testing effectiveness (Phase 2)UnknownNCT04830644
What this trial is testing
Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
Who this might be right for
Primary Sjögren Syndrome
Jiangsu Simcere Pharmaceutical Co., Ltd. 144